{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:37:11Z","timestamp":1769225831740,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/won.0b013e3181b414ed","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T01:58:04Z","timestamp":1302227884000},"page":"509-511","source":"Crossref","is-referenced-by-count":7,"title":["Topical Treatment Protocol for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis"],"prefix":"10.1097","volume":"36","author":[{"given":"Jill","family":"Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","article-title":"Toxic epidermal necrolysis clinical guidelines.","volume":"29","author":"Endorf","year":"2008","journal-title":"J Burn Care Rehabil"},{"issue":"3","key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/WON.0b013e3181a1a1ec","article-title":"Topical treatment protocol for Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"36","author":"Edwards","year":"2009","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"24","key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"R4-7-20210211","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Mediation use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BCR.0b013e31815f3658","article-title":"Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?","volume":"29","author":"Abood","year":"2008","journal-title":"J Burn Care Rehabil"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens Johnson syndrome and toxic epidermal necrolysis.","volume":"7","author":"Borchers","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"12","key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"issue":"2","key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.2005.07023.x","article-title":"The CD40\/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis spectrum.","volume":"154","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"R9-7-20210211","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00403-005-0607-3","article-title":"Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.","volume":"297","author":"Paquet","year":"2005","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors.","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.bcr.0000194268.01514.f8","article-title":"Long-term follow-up of patients treated for toxic epidermal necrolysis.","volume":"1","author":"Oplatek","year":"2006","journal-title":"J Burn Care Rehabil"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century.","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004630-199920060-00012","article-title":"Management of severe toxic epidermal necrolysis in children.","volume":"20","author":"Sheridan","year":"1999","journal-title":"J Burn Care Rehabil"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004630-199709000-00008","article-title":"Toxic epidermal necrolysis.","volume":"18","author":"Murphy","year":"1997","journal-title":"J Burn Care Rehabil"},{"key":"R16-7-20210211","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.108.5.1162","article-title":"Treatment of extensive toxic epidermal necrolysis in children.","volume":"108","author":"Spies","year":"2001","journal-title":"Pediatrics"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"A 10-year experience with toxic epidermal necrolysis.","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care Rehabil"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00004630-199909000-00013","article-title":"Skin coverage with Biobrane biomaterial for the treatment of patients with toxic epidermal necrolysis.","volume":"20","author":"Arevalo","year":"1991","journal-title":"J Burn Care Rehabil"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.BCR.0000150298.57472.26","article-title":"Therapeutic efficacy of three silver dressings in an infected animal model.","volume":"26","author":"Heggers","year":"2005","journal-title":"J Burn Care Rehabil"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00004630-199811000-00013","article-title":"A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.","volume":"19","author":"Tredget","year":"1998","journal-title":"J Burn Care Rehabil"},{"key":"R21-7-20210211","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1016\/j.jpedsurg.2006.08.043","article-title":"Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing.","volume":"41","author":"Asz","year":"2006","journal-title":"J Pediatric Surg"}],"container-title":["Journal of Wound, Ostomy & Continence Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WON.0b013e3181b414ed","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:29:01Z","timestamp":1620977341000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00152192-200909000-00007"}},"subtitle":["A Brief Report"],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/won.0b013e3181b414ed","relation":{},"ISSN":["1071-5754"],"issn-type":[{"value":"1071-5754","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}